Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2018-03-13 | 2018-10-11 | 42622 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-08-14 | 2018-01-03 | 19304 |
| RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2017-03-17 | 2017-07-28 | 3137 |
| RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2019-07-02 | 2019-07-16 | 88167 |
| RATIO-IPRATROPIUM UDV | 250MCG | SOLUTION | Resolved | 2017-05-23 | 2017-09-19 | 10892 |
| TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2017-08-14 | 2017-09-19 | 19308 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-05-10 | 2017-09-19 | 9785 |
| TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2017-08-01 | 2017-09-19 | 17839 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42582 |
| RATIO-LACTULOSE | 667MG/ML | BOTTLE | Resolved | 2017-03-14 | 2017-12-15 | 2400 |
| RATIO-LACTULOSE | 667MG | SOLUTION | Resolved | 2024-05-03 | 2024-09-19 | 226933 |
| TEVA-LENOLTEC NO. 2 | 300MG 15MG 15MG | TABLET | Resolved | 2017-03-17 | 2017-09-05 | 3118 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2017-03-15 | 2017-12-15 | 2986 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2017-03-17 | 2017-09-05 | 3121 |
| RATIO-METFORMIN | 850MG | TABLET | Resolved | 2017-04-03 | 2017-10-10 | 5168 |
| RATIO-METFORMIN | 850MG | TABLET | Resolved | 2019-09-05 | 2020-07-10 | 93162 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2017-11-16 | 2018-01-04 | 29441 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-13 | 2020-02-13 | 1739 |
| TEVA-NYSTATIN | 100000UNIT | DROPS | Resolved | 2017-03-14 | 2018-03-08 | 2410 |
| RATIO-NYSTATIN | 100000UNIT | OINTMENT | Resolved | 2017-03-17 | 2017-09-05 | 3145 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |